888 related articles for article (PubMed ID: 25358521)
1. Relationship of fluconazole prophylaxis with fungal microbiology in hospitalized intra-abdominal surgery patients: a descriptive cohort study.
Zilberberg M; Yu HT; Chaudhari P; Emons MF; Khandelwal N; Shorr AF
Crit Care; 2014 Oct; 18(5):590. PubMed ID: 25358521
[TBL] [Abstract][Full Text] [Related]
2. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
3. Candidemia: the impact of antifungal prophylaxis in a surgical intensive care unit.
Swoboda SM; Merz WG; Lipsetta PA
Surg Infect (Larchmt); 2003; 4(4):345-54. PubMed ID: 15012861
[TBL] [Abstract][Full Text] [Related]
4. Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp.
Playford EG; Marriott D; Nguyen Q; Chen S; Ellis D; Slavin M; Sorrell TC
Crit Care Med; 2008 Jul; 36(7):2034-9. PubMed ID: 18552700
[TBL] [Abstract][Full Text] [Related]
5. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
[TBL] [Abstract][Full Text] [Related]
6. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP
Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
[TBL] [Abstract][Full Text] [Related]
7. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia.
Shorr AF; Lazarus DR; Sherner JH; Jackson WL; Morrel M; Fraser VJ; Kollef MH
Crit Care Med; 2007 Apr; 35(4):1077-83. PubMed ID: 17312565
[TBL] [Abstract][Full Text] [Related]
8. Impact of therapeutic strategies on the prognosis of candidemia in the ICU.
Puig-Asensio M; Pemán J; Zaragoza R; Garnacho-Montero J; Martín-Mazuelos E; Cuenca-Estrella M; Almirante B; ; ; ;
Crit Care Med; 2014 Jun; 42(6):1423-32. PubMed ID: 24557426
[TBL] [Abstract][Full Text] [Related]
9. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy.
Hachem R; Hanna H; Kontoyiannis D; Jiang Y; Raad I
Cancer; 2008 Jun; 112(11):2493-9. PubMed ID: 18412153
[TBL] [Abstract][Full Text] [Related]
10. Candida norvegensis fungemia in a liver transplant recipient.
Sanclemente G; Marco F; Cervera C; Hoyo I; Colmenero J; Pitart C; Almela M; Navasa M; Moreno A
Rev Iberoam Micol; 2015; 32(2):115-7. PubMed ID: 24794213
[TBL] [Abstract][Full Text] [Related]
11. Empirical treatment of candidemia in intensive care units: fluconazole or broad-spectrum antifungal agents?
Guinea J; Peláez T; Rodríguez-Créixems M; Torres-Narbona M; Muñoz P; Alcalá L; Bouza E
Med Mycol; 2009; 47(5):515-20. PubMed ID: 18972315
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, susceptibility profile for fluconazole and risk factors for candidemia in a tertiary care hospital in southern Brazil.
Aquino VR; Lunardi LW; Goldani LZ; Barth AL
Braz J Infect Dis; 2005 Oct; 9(5):411-8. PubMed ID: 16410893
[TBL] [Abstract][Full Text] [Related]
13. Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital.
Girão E; Levin AS; Basso M; Gobara S; Gomes LB; Medeiros EA; Costa SF
Med Mycol; 2008 Sep; 46(6):581-8. PubMed ID: 19180727
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of Candida blood stream infections: experience of a tertiary care centre in North India.
Chander J; Singla N; Sidhu SK; Gombar S
J Infect Dev Ctries; 2013 Sep; 7(9):670-5. PubMed ID: 24042103
[TBL] [Abstract][Full Text] [Related]
15. The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer.
Bodey GP; Mardani M; Hanna HA; Boktour M; Abbas J; Girgawy E; Hachem RY; Kontoyiannis DP; Raad II
Am J Med; 2002 Apr; 112(5):380-5. PubMed ID: 11904112
[TBL] [Abstract][Full Text] [Related]
16. Candidemia in intensive care unit patients: a one year study from a tertiary care center in South India.
Giri S; Kindo AJ; Kalyani J
J Postgrad Med; 2013; 59(3):190-5. PubMed ID: 24029196
[TBL] [Abstract][Full Text] [Related]
17. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
Krcmery V; Barnes AJ
J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
[TBL] [Abstract][Full Text] [Related]
18. Incidence of candidaemia and relationship with fluconazole use in an intensive care unit.
Bassetti M; Ansaldi F; Nicolini L; Malfatto E; Molinari MP; Mussap M; Rebesco B; Bobbio Pallavicini F; Icardi G; Viscoli C
J Antimicrob Chemother; 2009 Sep; 64(3):625-9. PubMed ID: 19622536
[TBL] [Abstract][Full Text] [Related]
19. Breakthrough candidemia after the introduction of broad spectrum antifungal agents: A 5-year retrospective study.
Breda GL; Tuon FF; Meis JF; Herkert PF; Hagen F; de Oliveira LZ; Dias VC; da Cunha CA; Queiroz-Telles F
Med Mycol; 2018 Jun; 56(4):406-415. PubMed ID: 29420820
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
